What is the estimated overvaluation percentage of Calumet (CLMT) stock, and what key factors drive this assessment?

Calumet (CLMT) is estimated to be 21.6% overvalued at its current price of $47.19, with a fair value of $38.80; this assessment is primarily driven by the company's reliance on renewable fuel regulations and its substantial debt load.

What conflicting valuation signals does the article present for Calumet (CLMT), and how do they differ?

The article presents conflicting valuation signals: one narrative deems CLMT 21.6% overvalued at $47.19 versus a fair value of $38.80, while a discounted cash flow (DCF) model suggests potential undervaluation at $72.27 — indicating mixed signals on its true value.

ChemBrief

Topics Daily Digest Tags

Calumet (CLMT) Could Be 22% Overvalued Amid Strait of Hormuz Oil Jitters

Aug 13, 2026

Calumet Specialty Products Partners faces mixed valuation signals as Strait of Hormuz tensions drive up Brent crude prices. Analysts debate whether the stock is overvalued at $47.19 due to debt and renewable fuel reliance or potentially undervalued based on DCF models.

Yahoo Finance

2026-03-30

Adams Asset Advisors LLC Holds $102.46M Stake in Calumet, Inc.

2026-03-30

Calumet (NASDAQ:CLMT) Given New $60.00 Price Target at HC Wainwright

2026-03-31

H.C. Wainwright Raises Calumet Stock Price Target to $60 from $33

2026-04-02

Calumet (NASDAQ:CLMT) Director Daniel Sajkowski Sells 3,310 Shares

2026-04-05

Calumet, Inc. Receives Consensus 'Hold' Rating from Brokerages